| scholarly article | Q13442814 |
| P2093 | author name string | Jose Serrano | |
| Naga Chalasani | |||
| Herbert L Bonkovsky | |||
| Robert Fontana | |||
| Qing Zong | |||
| Jianying Wang | |||
| Karrie Tartaro | |||
| Patricia Schneider | |||
| Ellen Olson | |||
| Jessica Whritenour | |||
| Maria Van Volkenburg | |||
| Mira Ko | |||
| Paul Hayashi | |||
| P2860 | cites work | Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. | Q51790664 |
| In vitro detection of cytotoxic T and NK cells in peripheral blood of patients with various drug-induced skin diseases. | Q53368356 | ||
| In vitro tests in drug hypersensitivity diagnosis. | Q53386617 | ||
| Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury. | Q53497512 | ||
| ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury | Q60962648 | ||
| Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption | Q81553544 | ||
| Evaluation of isoniazid-associated hepatitis by immunological tests | Q28332812 | ||
| Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance | Q28538041 | ||
| Mechanisms of drug-induced liver injury: from bedside to bench | Q34169362 | ||
| Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network | Q34943114 | ||
| Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles | Q35085772 | ||
| Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method | Q35644300 | ||
| Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study | Q35656015 | ||
| The lymphocyte transformation test in the diagnosis of drug hypersensitivity | Q35824801 | ||
| Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury | Q35841174 | ||
| Immunological mechanisms of drug-induced liver injury. | Q36023323 | ||
| Allergic hepatitis induced by drugs | Q36529588 | ||
| Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury | Q36668300 | ||
| Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop | Q36740188 | ||
| Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury | Q36744793 | ||
| Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct | Q36799781 | ||
| Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States | Q36844723 | ||
| Amoxicillin-Clavulanate-Induced Liver Injury. | Q37095609 | ||
| Important elements for the diagnosis of drug-induced liver injury | Q37512625 | ||
| Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations | Q37624916 | ||
| A fresh look at the mechanism of isoniazid-induced hepatotoxicity | Q37853833 | ||
| In vitro diagnosis of delayed-type drug hypersensitivity: mechanistic aspects and unmet needs | Q38228927 | ||
| Herbal products and the liver: a review of adverse effects and mechanisms | Q38286959 | ||
| Validity study of a new diagnostic scale for drug-induced liver injury in Japan-comparison with two previous scales. | Q40461992 | ||
| Detection and analysis of intracytoplasmic cytokines in peripheral blood mononuclear cells in patients with drug-induced liver injury | Q40652329 | ||
| Lymphocyte stimulation test with tetrazolium-based colorimetric assay for diagnosis of drug-induced allergic hepatitis | Q40698955 | ||
| Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis | Q42180870 | ||
| The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis. | Q42264508 | ||
| Detection of hypersensitivity to drugs by lymphocyte cultures in drug-induced allergic hepatitis | Q45111264 | ||
| In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test | Q47749838 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 31-38 | |
| P577 | publication date | 2017-12-01 | |
| P1433 | published in | Journal of Immunotoxicology | Q6295320 |
| P1476 | title | Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. | |
| P478 | volume | 14 |
| Q47769405 | A perspective on the challenges and issues in developing biomarkers for human allergic risk assessments |
| Q57807859 | Drug-Induced Liver Injury: Highlights of the Recent Literature |
| Q95572129 | Drug-induced liver injury |
| Q92556667 | Mechanistic Studies of Idiosyncratic DILI: Clinical Implications |
| Q92324950 | Tools for causality assessment in drug-induced liver disease |
Search more.